Chloe Orkin, MD, MSc, discusses the takeaways of the ARTISTRY-1 phase 3 study, including its efficacy and safety profile and the potential benefits of a single-tablet regimen in this patient population.
Chloe Orkin, MD, MSc
Advertisement
Orkin is a professor of Queen Mary University of London.
Articles by Chloe Orkin, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
HIV in 2026: Four Experts on Aging, Testing, Equity, and Prevention's Next Era
2
Merck, ADAP Crisis Task Force Agree to Expand IDVYNSO Access in HIV
3
Lenacapavir and the Future of HIV Prevention: PURPOSE Trials, Long-Acting PrEP, and What Comes Next
4
mRNA Influenza Vaccine Advances Against Multiple Strains
5